New Ilc Dover India Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 10.00 K
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 12576.02%
- Profit Growth 1216.29%
- Ebitda 3980.40%
- Net Worth 965769.60%
- Total Assets 3607.76%
About New Ilc Dover India
New Ilc Dover India Private Limited (NIDIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 22 October 2021 (Three years and four months 6 days old ). Its registered office is in Gurgaon, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Devashish Ohri, Patrick Weinberg, and Chitra Joshi serve as directors at the Company.
Company Details
- Location
Gurgaon, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999HR2021FTC098624
- Company No.
098624
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
22 Oct 2021
- Date of AGM
04 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at New Ilc Dover India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devashish Ohri  | Director | 22-Oct-2021 | Current |
Patrick Weinberg  | Director | 29-Sep-2022 | Current |
| Chitra Joshi | Director | 04-Aug-2023 | Current |
Financial Performance of New Ilc Dover India.
New Ilc Dover India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12576.02% increase. The company also saw a substantial improvement in profitability, with a 1216.29% increase in profit. The company's net worth Soared by an impressive increase of 965769.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of New Ilc Dover India?
In 2023, New Ilc Dover India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nextgen In-Vitro Diagnostics Private LimitedDevashish Ohri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at New Ilc Dover India?
New Ilc Dover India has a workforce of 11 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of New Ilc Dover India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Ilc Dover India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
